SluitenHelpPrint
Switch to English
Cursus: FA-CPS101
FA-CPS101
Epidemiology and Clinical Development of New Drugs
Cursus informatieRooster
CursuscodeFA-CPS101
Studiepunten (ECTS)15
Categorie / Niveau1 (Bachelor Inleiding)
CursustypeCursorisch onderwijs
VoertaalEngels
Aangeboden doorFaculteit Betawetenschappen; School of Pharmacy, fac. Betawetenschappen;
ContactpersoonH. Gardarsdottir
E-mailh.gardarsdottir@uu.nl
Docenten
Contactpersoon van de cursus
H. Gardarsdottir
Overige cursussen docent
Docent
dr. ir. I. Meijerman
Overige cursussen docent
Blok
1  (03-09-2018 t/m 09-11-2018)
Aanvangsblok
1
Timeslot-: Niet van toepassing
Onderwijsvorm
Voltijd
OpmerkingHonours programme
Cursusinschrijving geopendvanaf 28-05-2018 t/m 24-06-2018
AanmeldingsprocedureOsiris
Inschrijven via OSIRISJa
Inschrijven voor bijvakkersNee
VoorinschrijvingNee
Na-inschrijvingJa
Na-inschrijving geopendvanaf 20-08-2018 t/m 21-08-2018
WachtlijstJa
PlaatsingsprocedureStudiepunt/Student desk
Cursusdoelen
After this course you will be able to:
1. Recognize the research-cycle
2. Design, execute and process the data of a simple in vivo experiment
3. Design and process the data of a clinical study
4. Express a critical attitude towards evidence based medicine and ethical aspects of pharmaceutical research
5. Use literature databases
6. Write a report and review the reports of other students
7. Use basic statistical tests and basic epidemiology methods to process data of experiments and clinical trials
8. Execute basic meeting skills
Inhoud
 Working Methods
Project work, which will consist of two parts: ‘The Disease File’ and ‘The Clinical Trial’. Furthermore there will be lectures, workshops, in particular on statistics, study design, and literature search, and the design and execution of an in vivo experiment. Every Friday afternoon there will be ‘Quite Interesting Afternoon’- meetings. In these meetings you will reflect on what you have learned. 
 
Contents
We all know people that use medication, like for chronic diseases, infections and for a headache. But what kind of drugs are there anyway, and how do we know that they are effective? Currently there are many drugs on the market for multiple diseases. They could only enter the market after their efficacy and safety was thoroughly investigated in clinical trials, first in human volunteers (phase I) and later on in groups of patients (phase II and III). This clinical process however cannot guarantee that all adverse effects are revealed and efficacy is efficiently proven. Therefore epidemiologic research and post-marketing studies are necessary to get real ‘evidence-based’ drugs. In this course you will learn about epidemiology and clinical trials. Furthermore, you will learn basic statistics used to perform clinical and epidemiological research. In addition, you will be introduced into literature research so that you can find your way around in literature databases to find the information you will need for your project.
 
 
Competenties
-
Ingangseisen
Je moet voldoen aan de volgende eisen
  • Ingeschreven voor een opleiding van de faculteit Faculteit Betawetenschappen
Verplicht materiaal
Boek
“Medical Statistics at a Glance” of A. Petrie and C. Sabin (2009)
Boek
“Drug Discovery and Development – Technology in Transition” of H.P. Rang (2006).
Software
SPSS
Werkvormen
Groepsonderwijs

Hoorcollege

Werkcollege

Toetsen
Eindresultaat
Weging100
Minimum cijfer-

Beoordeling
The grade is based on the assessment of the reports and presentations of the different projects, and the grade for the individual exam.

SluitenHelpPrint
Switch to English